{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:53:41Z","timestamp":1792122821572,"version":"4.4.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The prospect of eradicating malaria continues to be challenging in the face of increasing parasite resistance to antimalarial drugs so that novel antimalarials active against asexual, sexual, and liver-stage malaria parasites are urgently needed. In addition, new antimalarials need to be affordable and available to those most in need and, bearing in mind climate change, should ideally be sustainable. The West African climbing shrub <jats:italic>Cryptolepis sanguinolenta<\/jats:italic> is used traditionally for the treatment of malaria; its principal alkaloid, cryptolepine (<jats:bold>1<\/jats:bold>), has been shown to have antimalarial properties, and the synthetic analogue 2,7-dibromocryptolepine (<jats:bold>2<\/jats:bold>) is of interest as a lead toward new antimalarial agents. Cryptolepine (<jats:bold>1<\/jats:bold>) was isolated using a two-step Soxhlet extraction of <jats:italic>C. sanguinolenta<\/jats:italic> roots, followed by crystallization (yield 0.8% calculated as a base with respect to the dried roots). Semi-synthetic 7-bromo- (<jats:bold>3<\/jats:bold>), 7, 9-dibromo- (<jats:bold>4<\/jats:bold>), 7-iodo- (<jats:bold>5<\/jats:bold>), and 7, 9-dibromocryptolepine (<jats:bold>6<\/jats:bold>) were obtained in excellent yields by reaction of <jats:bold>1<\/jats:bold> with <jats:italic>N<\/jats:italic>-bromo- or <jats:italic>N<\/jats:italic>-iodosuccinimide in trifluoroacetic acid as a solvent. All compounds were active against <jats:italic>Plasmodia in vitro<\/jats:italic>, but <jats:bold>6<\/jats:bold> showed the most selective profile with respect to Hep G2 cells: <jats:italic>P. falciparum<\/jats:italic> (chloroquine-resistant strain K1), IC<jats:sub>50<\/jats:sub> = 0.25\u00a0\u00b5M, SI = 113; late stage, gametocytes, IC<jats:sub>50<\/jats:sub> = 2.2\u00a0\u00b5M, SI = 13; liver stage, <jats:italic>P. berghei<\/jats:italic> sporozoites IC<jats:sub>50<\/jats:sub> = 6.13\u00a0\u00b5M, SI = 4.6. Compounds <jats:bold>3<\/jats:bold>\u2013<jats:bold>6<\/jats:bold> were also active against the emerging zoonotic species <jats:italic>P. knowlesi<\/jats:italic> with <jats:bold>5<\/jats:bold> being the most potent (IC<jats:sub>50<\/jats:sub> = 0.11\u00a0\u00b5M). In addition, <jats:bold>3<\/jats:bold>\u2013<jats:bold>6<\/jats:bold> potently inhibited <jats:italic>T. brucei in vitro<\/jats:italic> at nM concentrations and good selectivity with <jats:bold>6<\/jats:bold> again being the most selective (IC<jats:sub>50<\/jats:sub> = 59\u00a0nM, SI = 478). These compounds were also cytotoxic to wild-type ovarian cancer cells as well as adriamycin-resistant and, except for <jats:bold>5<\/jats:bold>, cisplatin-resistant ovarian cancer cells. In an acute oral toxicity test in mice, <jats:bold>3<\/jats:bold>\u2013<jats:bold>6<\/jats:bold> did not exhibit toxic effects at doses of up to 100\u00a0mg\/kg\/dose \u00d7 3 consecutive days. This study demonstrates that <jats:italic>C. sanguinolenta<\/jats:italic> may be utilized as a sustainable source of novel compounds that may lead to the development of novel agents for the treatment of malaria, African trypanosomiasis, and cancer.<\/jats:p>","DOI":"10.3389\/fphar.2022.875647","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T05:37:26Z","timestamp":1650951446000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and Cancer"],"prefix":"10.3389","volume":"13","author":[{"given":"Yabalu Z.","family":"Abacha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold Donkor","family":"Forkuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Y.","family":"Gbedema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimisha","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Ottilie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Rocamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Winzeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donelly A.","family":"van Schalkwyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette","family":"Reader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn-Marie","family":"Birkholtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Lisgarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy K.","family":"Cockcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Lisgarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rex A.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary C.","family":"Talbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Shnyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin W.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"E1214","DOI":"10.1073\/pnas.1112037108","article-title":"Quantitative Assessment of Plasmodium Falciparum Sexual Development Reveals Potent Transmission-Blocking Activity by Methylene Blue","volume":"108","author":"Adjalley","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5897\/JMPR2015.5793","article-title":"Influence of Age and Staking on the Growth and Cryptolepine Concentration in Cultivated Roots of Cryptolepis Sanguinolenta (Lindl.) Schlt","volume":"10","author":"Amissah","year":"2016","journal-title":"J. Med. Plants Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tox.2004.11.026","article-title":"In Vitro genotoxicity of the West African Anti-malarial Herbal Cryptolepis Sanguinolenta and its Major Alkaloid Cryptolepine","volume":"208","author":"Ansah","year":"2005","journal-title":"Toxicology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"eaat9446","DOI":"10.1126\/science.aat9446","article-title":"Open-source Discovery of Chemical Leads for Next-Generation Chemoprotective Antimalarials","volume":"362","author":"Antonova-Koch","year":"2018","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/bs.apar.2021.08.004","article-title":"Clinical Management of Plasmodium Knowlesi Malaria","volume":"113","author":"Barber","year":"2021","journal-title":"Adv. Parasitol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1128\/AAC.48.5.1807-1810.2004","article-title":"Novel, Rapid, and Inexpensive Cell-Based Quantification of Antimalarial Drug Efficacy","volume":"48","author":"Bennett","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1002\/ejoc.201700173","article-title":"N -Iodosuccinimide (NIS) in Direct Aromatic Iodination","volume":"2017","author":"Bergstr\u00f6m","year":"2017","journal-title":"Eur. J. Org. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1021\/bi972927q","article-title":"The DNA Intercalating Alkaloid Cryptolepine Interferes with Topoisomerase II and Inhibits Primarily DNA Synthesis in B16 Melanoma Cells","volume":"37","author":"Bonjean","year":"1998","journal-title":"Biochemistry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12936-017-1809-9","article-title":"Erratum to: New Developments in Anti-malarial Target Candidate and Product Profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1016\/S0040-4039(02)01010-9","article-title":"Mild and Regioselective Iodination of Electron-Rich Aromatics with N -iodosuccinimide and Catalytic Trifluoroacetic Acid","volume":"43","author":"Castanet","year":"2002","journal-title":"Tetrahedron Lett."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1021\/acs.jafc.0c06480","article-title":"Design, Synthesis, and Antifungal Evaluation of Cryptolepine Derivatives against Phytopathogenic Fungi","volume":"69","author":"Chen","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/tropicalmed5010029","article-title":"New Drugs for Human African Trypanosomiasis: A Twenty First century success story","volume":"5","author":"Dickie","year":"2020","journal-title":"Trop. Med. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s12936-017-2142-z","article-title":"In Vitro anti-malarial Interaction and Gametocytocidal Activity of Cryptolepine","volume":"16","author":"Forkuo","year":"2017","journal-title":"Malar. J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.toxlet.2011.09.010","article-title":"Effects of the Anti-malarial Compound Cryptolepine and its Analogues in Human Lymphocytes and Sperm in the Comet Assay","volume":"207","author":"Gopalan","year":"2011","journal-title":"Toxicol. Lett."},{"key":"B14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/(sici)1099-1573(199606)10:4<317::aid-ptr858>3.0.co;2-0","article-title":"Antimalarial Activity of Cryptolepine and Isocryptolepine, Alkaloids Isolated fromCryptolepis Sanguinolenta","volume":"10","author":"Grellier","year":"1996","journal-title":"Phytother. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nsb729","article-title":"The Antimalarial and Cytotoxic Drug Cryptolepine Intercalates into DNA at Cytosine-Cytosine Sites","volume":"9","author":"Lisgarten","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.4269\/ajtmh.1993.48.739","article-title":"Parasite Lactate Dehydrogenase as an Assay for Plasmodium Falciparum Drug Sensitivity","volume":"48","author":"Makler","year":"1993","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/1934578X0900400205","article-title":"Evaluation of Cryptolepine and Huperzine Derivatives as lead Compounds towards New Agents for the Treatment of Human African Trypanosomiasis","volume":"4","author":"Oluwafemi","year":"2009","journal-title":"Nat. Prod. Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1021\/jm040893w","article-title":"Synthesis of Some Cryptolepine Analogues, Assessment of Their Antimalarial and Cytotoxic Activities, and Consideration of Their Antimalarial Mode of Action","volume":"48","author":"Onyeibor","year":"2005","journal-title":"J. Med. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0007381","DOI":"10.1371\/journal.pntd.0007381","article-title":"The European Medicines Agency's Scientific Opinion on Oral Fexinidazole for Human African Trypanosomiasis","volume":"13","author":"Pelfrene","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12936-015-0718-z","article-title":"Nowhere to Hide: Interrogating Different Metabolic Parameters of Plasmodium Falciparum Gametocytes in a Transmission Blocking Drug Discovery Pipeline towards Malaria Elimination","volume":"14","author":"Reader","year":"2015","journal-title":"Malar. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41467-020-20629-8","article-title":"Multistage and Transmission-Blocking Targeted Antimalarials Discovered from the Open-Source MMV Pandemic Response Box","volume":"12","author":"Reader","year":"2021","journal-title":"Nat. Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1021\/np070477p","article-title":"Sodium Pancratistatin 3,4-O-Cyclic Phosphate, a Water-Soluble Synthetic Derivative of Pancratistatin, Is Highly Effective in a Human colon Tumor Model","volume":"71","author":"Shnyder","year":"2008","journal-title":"J. Nat. Prod."},{"key":"B24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-3-030-64853-4_4","article-title":"Recent Advances in the Chemistry and Pharmacology of Cryptolepine","volume":"115","author":"Shnyder","year":"2021","journal-title":"Prog. Chem. Org. Nat. Prod."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and Inexpensive Fluorescence-Based Technique for High-Throughput Antimalarial Drug Screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1021\/np50095a001","article-title":"Cryptospirolepine, a Unique spiro-nonacyclic Alkaloid Isolated from Cryptolepis Sanguinolenta","volume":"56","author":"Tackie","year":"1993","journal-title":"J. Nat. Prod."},{"key":"B27","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/mmi.12285","article-title":"Evidence that Transport of Iron from the Lysosome to the Cytosol in African Trypanosomes Is Mediated by a Mucolipin Orthologue","volume":"89","author":"Taylor","year":"2013","journal-title":"Mol. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human Malaria Parasites in Continuous Culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpddr.2019.02.004","article-title":"Plasmodium Knowlesi Exhibits Distinct In Vitro Drug Susceptibility Profiles from Those of Plasmodium Falciparum","volume":"9","author":"van Schalkwyk","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1093\/jac\/dkx279","article-title":"Comparison of the Susceptibility of Plasmodium Knowlesi and Plasmodium Falciparum to Antimalarial Agents","volume":"72","author":"van Schalkwyk","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"B31","unstructured":"Trypanosomiasis, Human African (Sleeping Sickness)2021"},{"key":"B32","volume-title":"Global Technical Strategy for Malaria 2016-2030","author":"WHO","year":"2016"},{"key":"B33","unstructured":"World Malaria Report 2021: Regional Data and Trends2021"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1021\/jm010929+","article-title":"Synthesis and Evaluation of Cryptolepine Analogues for Their Potential as New Antimalarial Agents","volume":"44","author":"Wright","year":"2001","journal-title":"J. Med. Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(sici)1099-1573(199606)10:4<361::aid-ptr845>3.0.co;2-n","article-title":"Antimalarial Activity of Cryptolepine and Some Other Anhydronium Bases","volume":"10","author":"Wright","year":"1996","journal-title":"Phytother. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.875647\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T15:21:50Z","timestamp":1651764110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.875647\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":35,"alternative-id":["10.3389\/fphar.2022.875647"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.875647","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]},"article-number":"875647"}}